Cargando…
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA*
OBJECTIVES: All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe. METHODS: EuroSIDA patients with viraemic HCV infectio...
Autores principales: | Grint, D, Peters, L, Schwarze-Zander, C, Beniowski, M, Pradier, C, Battegay, M, Jevtovic, D, Soriano, V, Lundgren, JD, Rockstroh, JK, Kirk, O, Mocroft, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030620/ https://www.ncbi.nlm.nih.gov/pubmed/23869664 http://dx.doi.org/10.1111/hiv.12068 |
Ejemplares similares
-
HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
por: Peters, Lars, et al.
Publicado: (2014) -
Regional differences in self-reported HIV care and management in the EuroSIDA study
por: Grønborg Laut, Kamilla, et al.
Publicado: (2014) -
Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA
por: Ryom, L, et al.
Publicado: (2010) -
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
por: Viard, JP, et al.
Publicado: (2010) -
Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study
por: Reekie, Joanne, et al.
Publicado: (2012)